Table of Content

Scope and Methodology
1.1. Research Methodology
1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary
3.1. Market Snippet by Treatment Type
3.2. Market Snippet by Medication Type
3.3. Market Snippet by End User
3.4. Market Snippet by Region

4. Market Dynamics
4.1. Market impacting factors
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Impact analysis

5. Industry Analysis
5.1. Porter’s five forces analysis
5.2. Value chain analysis
5.3. Patent Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives

7. By Treatment Type
7.1. Introduction
7.1.1. Market size analysis, and y-o-y growth analysis (%), By Treatment Type Segment
7.1.2. Market attractiveness index, By Treatment Type Segment
7.2. Heart Transplantation*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
7.3. Liver Transplantation

8. By Medication Type
8.1. Introduction
8.1.1. Market size analysis, and y-o-y growth analysis (%), By Medication Type Segment
8.1.2. Market attractiveness index, By Medication Type Segment
8.2. Tafamidis meglumine *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
8.3. Tafamidis
8.4. RNAi therapy
8.5. Diuretics
8.6. Beta-blockers
8.7. Digoxin

9. By End User
9.1. Introduction
9.1.1. Market size analysis, and y-o-y growth analysis (%), By End User Segment
9.1.2. Market attractiveness index, By End User Segment
9.2. Hospital Pharmacies*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
9.3. Retail Pharmacies
9.4. Online Pharmacies

10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key region-specific dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. South America
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.3.6.1. Brazil
10.3.6.2. Argentina
10.3.6.3. Rest of South America
10.4. Europe
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.4.6.1. Germany
10.4.6.2. U.K.
10.4.6.3. France
10.4.6.4. Spain
10.4.6.5. Italy
10.4.6.6. Rest of Europe
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape
11.1. Competitive scenario
11.2. Competitor strategy analysis
11.3. Market positioning/share analysis
11.4. Mergers and acquisitions analysis

12. Company Profiles
12.1. Pfizer Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Ionis Pharmaceuticals
12.3. BridgeBio Pharma
12.4. Alnylam Pharmaceuticals
12.5. Prothena Corporation
12.6. Regeneron Pharmaceuticals
12.7. Corino Therapeutics
12.8. Arcturus Therapeutics
12.9. Proclara Biosciences
*List not Exhaustive*

13. DataM
13.1. Appendix
13.2. About us and services
13.3. Contact us